146 related articles for article (PubMed ID: 15635797)
1. [Helicobacter pylori negative gastroduodenal lesions in subjects treated with NSAID].
Kunovská M; Díte P; Lata J; Dolina J; Prásek J
Vnitr Lek; 2000 Jul; 46(7):384-6. PubMed ID: 15635797
[TBL] [Abstract][Full Text] [Related]
2. Infection with Helicobacter pylori and long-term use of non-steroidal antiinflammatory drugs.
Vcev A; Ivandić A; Vceva A; Stimac D; Takac B; Mikolasević I; Jovanović S; Dmitrović B; Vuković D; Egić B
Acta Med Croatica; 1998; 52(1):27-31. PubMed ID: 9599813
[TBL] [Abstract][Full Text] [Related]
3. Specifics of Helicobacter pylori infection/NSAID effects in the elderly.
Davidovic M; Svorcan P; Milanovic P; Antovic A; Milosevic D
Rom J Gastroenterol; 2005 Sep; 14(3):253-8. PubMed ID: 16200236
[TBL] [Abstract][Full Text] [Related]
4. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
5. Use of NSAIDs and infection with Helicobacter pylori--what does the rheumatologist need to know?
Kiltz U; Zochling J; Schmidt WE; Braun J
Rheumatology (Oxford); 2008 Sep; 47(9):1342-7. PubMed ID: 18477642
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
[TBL] [Abstract][Full Text] [Related]
7. [Bleeding peptic ulcer. Prevalence of Helicobacter pylori and use of nonsteroidal anti-inflammatory drugs/acetylsalicylic acid].
Vestergård A; Bredahl K; de Muckadell OB; Pedersen OB; Hansen JM
Ugeskr Laeger; 2009 Jan; 171(4):235-9. PubMed ID: 19174039
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic characteristics and Helicobacter pylori infection in NSAID-associated gastric ulcer.
Kamada T; Hata J; Kusunoki H; Sugiu K; Tanimoto T; Mihara M; Hamada H; Kido S; Dongmei Q; Haruma K
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):98-102. PubMed ID: 16706819
[TBL] [Abstract][Full Text] [Related]
9. Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication.
Bobrzyński A; Beben P; Budzyński A; Bielański W; Plonka M; Konturek S
Med Sci Monit; 2002 Aug; 8(8):CR554-7. PubMed ID: 12165741
[TBL] [Abstract][Full Text] [Related]
10. Trends in the prevalence of peptic ulcer disease and Helicobacter pylori infection in family physician-referred uninvestigated dyspeptic patients in Hong Kong.
Xia B; Xia HH; Ma CW; Wong KW; Fung FM; Hui CK; Chan CK; Chan AO; Lai KC; Yuen MF; Wong BC
Aliment Pharmacol Ther; 2005 Aug; 22(3):243-9. PubMed ID: 16091062
[TBL] [Abstract][Full Text] [Related]
11. [Helicobacter pylori in patients with diabetes mellitus].
Kojecký V; Roubalík J; Bartoníková N
Vnitr Lek; 1993 Jun; 39(6):581-4. PubMed ID: 8212614
[TBL] [Abstract][Full Text] [Related]
12. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
13. Should we eradicate Helicobacter pylori before prescribing an NSAID? Result of a placebo-controlled study.
Schaeverbeke T; Broutet N; Zerbib F; Combe B; Bertin P; Lamouliatte H; Perié F; Joubert-Collin M; Mégraud F
Am J Gastroenterol; 2005 Dec; 100(12):2637-43. PubMed ID: 16393213
[TBL] [Abstract][Full Text] [Related]
14. Incidence and etiology of acute non-malignant upper gastrointestinal bleeding in northern Greece.
Tsesmeli NE; Kotsaftis PS; Savopoulos CG; Hatzitolios AI; Kaiafa GD; Kounanis AD; Karamitsos DT
J Gastroenterol Hepatol; 2007 Jul; 22(7):1009-13. PubMed ID: 17608846
[TBL] [Abstract][Full Text] [Related]
15. Helicobacter pylori and nonsteroidal anti-inflammatory drugs in perforations and bleeding of peptic ulcers.
Bobrzyński A; Konturek PC; Konturek SJ; Płonka M; Bielański W; Karcz D
Med Sci Monit; 2005 Mar; 11(3):CR132-5. PubMed ID: 15735566
[TBL] [Abstract][Full Text] [Related]
16. NSAID-induced ulcers.
Go MF
Acta Gastroenterol Latinoam; 1996; 26(2):115-8. PubMed ID: 9137667
[No Abstract] [Full Text] [Related]
17. Nonsteroidal anti-inflammatory drug use is a significant cause of peptic ulcer disease in a tertiary hospital in Singapore: a prospective study.
Ong TZ; Hawkey CJ; Ho KY
J Clin Gastroenterol; 2006 Oct; 40(9):795-800. PubMed ID: 17016134
[TBL] [Abstract][Full Text] [Related]
18. [Gastropathy caused by non-steroidal anti-inflammatory agents and its association with Helicobacter pylori].
Rodríguez-Hernández H; Jacobo-Karam JS; Jáquez-Quintana JO; Avila-Romero HG; Galván-Román L; Lara-Miranda SC; Sánchez-Anguiano LF
Rev Invest Clin; 2003; 55(3):254-9. PubMed ID: 14515669
[TBL] [Abstract][Full Text] [Related]
19. Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms.
Pilotto A; Seripa D; Franceschi M; Scarcelli C; Colaizzo D; Grandone E; Niro V; Andriulli A; Leandro G; Di Mario F; Dallapiccola B
Gastroenterology; 2007 Aug; 133(2):465-71. PubMed ID: 17681167
[TBL] [Abstract][Full Text] [Related]
20. Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations.
Konturek PC; Konturek SJ; Cześnikiewicz M; Płonka M; Bielański W
Med Sci Monit; 2002 Sep; 8(9):RA197-209. PubMed ID: 12218957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
